Display options
Share it on

Healthc Policy. 2010 Nov;6(2):24-32.

The commercialization of genomic research in Canada.

Healthcare policy = Politiques de sante

Yann Joly, Timothy Caulfield, Bartha M Knoppers, Eef Harmsen, Tomi Pastinen

Affiliations

  1. Assistant Professor, Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC.

PMID: 22043221 PMCID: PMC3016633

Abstract

The commercialization of academic research has been promoted by North American policy makers for over 30 years as a means of increasing university financing and to ensure that promising research would eventually find its way to the marketplace. The following issues paper constitutes a reflection on the impact of the Canadian commercialization framework on academic research in the field of genomics. It was written following two workshops and two independent studies organized by academic groups in Quebec (Centre of Genomics and Policy) and Alberta (Health Law Institute). The full sets of recommendations are available upon request to the authors.

References

  1. JAMA. 2003 Jan 22-29;289(4):454-65 - PubMed
  2. Genome Med. 2009 Feb 19;1(2):22 - PubMed
  3. JAMA. 2002 Jan 23-30;287(4):473-80 - PubMed
  4. Acad Med. 2006 Feb;81(2):137-45 - PubMed
  5. Nat Biotechnol. 2007 Aug;25(8):867-8 - PubMed
  6. Genet Med. 2007 Dec;9(12):850-5 - PubMed
  7. N Engl J Med. 2003 Dec 18;349(25):2452-9 - PubMed

Publication Types